Role and Place of Radiation Therapy in Complex Treatment of Patients with de novo Metastatic Breast Cancer. Literature Review and Clinical Observations
https://doi.org/10.37174/2587-7593-2025-8-3-35-44
Abstract
According to state-of-art clinical guidelines, the leading method of treatment for de novo metastatic breast cancer is systemic therapy. However, the possibility and feasibility of performing local methods in treating the primary lesion in the above mentioned patients, such as surgery and radiation therapy, is currently being actively studied. This article provides a review of modern literature data related to the issues of external beam radiation therapy in patients with de novo metastatic breast cancer and presents our own clinical observations.
About the Authors
E. V. Timoshkina
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Competing Interests:
Russian Federation
Ekaterina V. Timoshkina, +79104040067
24 Kashirskoe highway, Moscow 115478
Competing Interests:
Not declared
O. P. Trofimova
N.N. Blokhin National Medical Research Center of Oncology ; Russian Medical Academy of Continuous Professional Education
Russian Federation
Competing Interests:
Russian Federation
24 Kashirskoe highway, Moscow 115478
2/1 b1, Barrikadnaya str., Moscow 125993
Competing Interests:
Not declared
V. V. Glebovskaya
A.S. Loginov Moscow Clinical Scientific Center
Russian Federation
Competing Interests:
Russian Federation
86 Enthusiasts sh., Moscow 111123
Competing Interests:
Not declared
M. V. Chernykh
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Competing Interests:
Russian Federation
24 Kashirskoe highway, Moscow 115478
Competing Interests:
Not declared
S. I. Tkachev
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Competing Interests:
Russian Federation
24 Kashirskoe highway, Moscow 115478
Competing Interests:
Not declared
S. M. Ivanov
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Competing Interests:
Russian Federation
24 Kashirskoe highway, Moscow 115478
Competing Interests:
Not declared
References
1. Clinical guidelines for breast cancer treatment. 2021
2. Breast cancer. NCCN guideline version 4.2025.
3. Rashid OM, Nagahash M, Ramachandran S, et al. Resection of the Primary Tumor Improves Survival in Metastatic Breast Cancer by Reduction of Overall Tumor Burden. Surgery. 2013;153(6):771-8. https://doi.org/10.1016/j.surg.2013.02.002.
4. Liu H, Patel MR, Prescher JA, et al. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc Nat Acad of the USA. 2010;107(42):18115-20. https://doi.org/10.1073/pnas.1006732107
5. Fehm T, Sagalowsky A, Clifford E, et al. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clinical Cancer Research. 2002;8(7):2073-84. https://doi.org/10.1073/pnas.1006732107.
6. Pons-Tostivint E, Alouani E, Kirova Y, et al. Is there a role for locoregional treatment of the primary tumor in de novo metastatic breast cancer in the era of tailored therapies? Critical Reviews in Oncology/Hematology. 2021;157:103-6. https://doi.org/10.1016/j.critrevonc.2020.103146.
7. Soran A, Ozmen V, Ozbas S, et al. Randomized Trial Comparing Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at Presentation: Protocol MF07-01. Annals of Surgical Oncology. 2018;25(11):3141-9. https://doi.org/10.1245/s10434-018-6494-6
8. Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery. 2002;132:620-7. https://doi.org/10.1067/msy.2002.127544.
9. Bozhok АА, Topuzov EE, Semiglazov VF, et al. Possibilities of surgical treatment for disseminated breast cancer. Problems in Onkology. 2013;59(3):320-7. (In Russ.) https://doi.org/10.37469/0507‑3758‑2013‑59‑3‑320‑327
10. Chernova EV, Khaylenko VA, Artamonova EV, et al. Reasonability of the primary tumor removal in metastatic breast cancer patients at initial presentation. Russian Oncological Journal. 2013;(2):27-31. (in Russ.) https://doi.org/10.17816/onco39969
11. Bozhok AA, Topuzov EE, Zikiryakhodzhaev AD, et al. Evaluation of the scientific results of the study entitled “Opportunities for surgical treatment of patients with stage IV breast cancer” performed by Russian Society of Oncomammologists (RSOM). Tumors of Female Reproductive System. 2016;12(4):17-24. (In Russ.). https://doi.org/10.17650/1994-4098-2016-12-4-17-24
12. Blanchard DK, Shetty PB, Hilsenbeck S, et al. Association of surgery with improved survival in stage IV breast cancer patients. Annals of Surgery. 2008;247(5):732-8. https://doi.org/10.1097/SLA.0b013e3181656d32.
13. Babiera GV, Rao R, Feng L, et al. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Annals of Surgical Oncology. 2006;13(6):776-82. https://doi.org/10.1245/ASO.2006.03.033.
14. Lang JE, Tereffe W, Mitchell MP, et al. Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival. Annals of Surgical Oncology. 2013;20(6):1893-99. https://doi.org/10.1245/s10434-012-2844-y.
15. Rapiti E, Verkooijen HM, Vlastos G, et al. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. Journal of Clinical Oncology. 2006;24(18):2743-49. https://doi.org/10.1200/JCO.2005.04.2226.
16. Reinhorn D, Mutai R, Yerushalmi R, et al. Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis. Breast. 2021;58:173-81. https://doi.org/10.1016/j.breast.2021.05.003.
17. Pons-Tostivint E, Kirova Y, Lusque A, et al. Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis. Radiotherapy & Oncology. 2020;145:109-16. https://doi.org/10.1016/j.radonc.2019.12.019.
18. Kim BH, Kim S, Kim YI, et al. Development of an Individualized Prediction Calculator for the Benefit of Postoperative Radiotherapy in Patients with Surgically Resected De Novo Stage IV Breast Cancer. Cancers. 2020;12(8):2103. https://doi.org/10.3390/cancers12082103.
19. Bliganov PI, Ivanov VA, Chernykh MV et al. Stereotactic radiation therapy of brain metastases: efficacy and toxicity of treatment. Surgery and Oncology. 2025;15(2):32-40. (In Russ.). https://doi.org/10.17650/2949-5857-2025-15-2-32-40
20. Bourgier C, Khodari W, Vataire AL, et al. Breast radiotherapy as part of loco-regional treatments in stage IV breast cancer patients with oligometastatic disease. Radiotherapy and Oncology. 2010:96:199-203. https://doi.org/10.1016/j.radonc.2010.02.028.
21. Le Scodan R, Stevens D, Brain E, et al. Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy. Journal of Clinical Oncology. 2009;27:1375-81. https://doi.org/10.1200/JCO.2008.19.5396
Review
For citations:
Timoshkina E.V., Trofimova O.P., Glebovskaya V.V., Chernykh M.V., Tkachev S.I., Ivanov S.M. Role and Place of Radiation Therapy in Complex Treatment of Patients with de novo Metastatic Breast Cancer. Literature Review and Clinical Observations. Journal of oncology: diagnostic radiology and radiotherapy. 2025;8(3):35-44. (In Russ.) https://doi.org/10.37174/2587-7593-2025-8-3-35-44
Views:
18
Email this article 